Correction: Maarof et al. Biodegradable Carbonate Apatite Nanoparticle as a Delivery System to Promote Afatinib Delivery for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 2022, 14, 1230

Nian N. N. Maarof; Emilia Abdulmalek; Sharida Fakurazi; Mohd Basyaruddin Abdul Rahman

doi:10.3390/pharmaceutics16101279

,

and

¹

Integrated Chemical BioPhysics Research, Department of Chemistry, Faculty of Science, Universiti Putra Malaysia, Serdang 43400, Selangor, Malaysia

²

Department of Chemistry, College of Education, University of Sulaimani, Sulaimani 46001, Iraq

³

Laboratory of Vaccines and Immunotherapeutics, Institute of Bioscience, Universiti Putra Malaysia UPM, Serdang 43400, Selangor, Malaysia

⁴

Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia UPM, Serdang 43400, Selangor, Malaysia

Pharmaceutics2024, 16(10), 1279;https://doi.org/10.3390/pharmaceutics16101279

This article belongs to the Special Issue Pharmaceutical and Bioengineering Advances in Medicine

Version Notes

Order Reprints

In the original publication, there was a mistake in the legend for “Figure 3”. The transmittance changes due to afatinib loading into nCA are mentioned in the green box. The correct legend appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Figure 3. FTIR spectra for nCA (red), nCA/AFA (blue), and AFA (green).

Reference

Maarof, N.N.N.; Abdulmalek, E.; Fakurazi, S.; Rahman, M.B.A. Biodegradable Carbonate Apatite Nanoparticle as a Delivery System to Promote Afatinib Delivery for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 2022, 14, 1230. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Correction: Maarof et al. Biodegradable Carbonate Apatite Nanoparticle as a Delivery System to Promote Afatinib Delivery for Non-Small Cell Lung Cancer Treatment. Pharmaceutics 2022, 14, 1230

Reference

Article Metrics

Citations

Article Access Statistics